These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 30819908)
21. A 9-month-old infant with acquired idiopathic thrombotic thrombocytopenic purpura caused by inhibitory IgG-autoantibody to ADAMTS13. Sato A; Hoshi Y; Onuma M; Sato R; Tsunematsu Y; Isonishi A; Matsumoto M; Fujimura Y; Imaizumi M Pediatr Hematol Oncol; 2010 Feb; 27(1):53-8. PubMed ID: 20121555 [TBL] [Abstract][Full Text] [Related]
22. Unique case of autoantibody mediated inactivation of ADAMTS13 in an Indian TTP patient. Bhakuni T; Singhal R; Annarapu GK; Sharma A; Mahapatra M; Saxena R; Guchhait P Blood Cells Mol Dis; 2019 Jul; 77():29-33. PubMed ID: 30953939 [TBL] [Abstract][Full Text] [Related]
23. A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy. Nikolaou M; Karakantza M; Adonakis G; Theodorou G; Zoumbos N; Decavalas G Med Pregl; 2012; 65(9-10):436-9. PubMed ID: 23214340 [TBL] [Abstract][Full Text] [Related]
24. Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. Kremer Hovinga JA; Lämmle B Hematology Am Soc Hematol Educ Program; 2012; 2012():610-6. PubMed ID: 23233642 [TBL] [Abstract][Full Text] [Related]
25. [Clinical observation of a patient with thrombotic thrombocytopenic purpura with renal and intestinal lesions]. Stolyar AG; Avdonin PV; Valamina IE; Stolyarevich ES Ter Arkh; 2019 Jul; 91(7):106-110. PubMed ID: 32598743 [TBL] [Abstract][Full Text] [Related]
26. [Thrombotic thrombocytopenic purpura induced by antibody to von Willebrand factor-cleaving protease]. Yagi H Rinsho Ketsueki; 2002 Jun; 43(6):468-72. PubMed ID: 12134703 [No Abstract] [Full Text] [Related]
27. Identification of Biomarkers in Patients with Thrombotic Thrombocytopenic Purpura Presenting with Large and Small Ischemic Stroke. Lin C; Memon R; Sui J; Zheng XL Cerebrovasc Dis Extra; 2021; 11(1):29-36. PubMed ID: 33601375 [TBL] [Abstract][Full Text] [Related]
28. Thrombotic thrombocytopenic purpura: a moving target. Sadler JE Hematology Am Soc Hematol Educ Program; 2006; ():415-20. PubMed ID: 17124092 [TBL] [Abstract][Full Text] [Related]
29. Influenza A infection triggers thrombotic thrombocytopenic purpura by producing the anti-ADAMTS13 IgG inhibitor. Kosugi N; Tsurutani Y; Isonishi A; Hori Y; Matsumoto M; Fujimura Y Intern Med; 2010; 49(7):689-93. PubMed ID: 20371960 [TBL] [Abstract][Full Text] [Related]
30. [Transplantation related ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: a case report and literature review]. Zhang W; Han Y; Su J; Bai X; Jin S; Xu M; Sun A; Ruan C; Wu D Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):69-70. PubMed ID: 24602740 [No Abstract] [Full Text] [Related]
31. The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura. Starke R; Machin S; Scully M; Purdy G; Mackie I Br J Haematol; 2007 Feb; 136(4):649-55. PubMed ID: 17367414 [TBL] [Abstract][Full Text] [Related]
33. Acquired thrombotic thrombocytopenic purpura due to antibody-mediated ADAMTS13 deficiency precipitated by a localized Castleman's disease: a case report. Benevides TC; Orsi FA; Colella MP; Percout Pde O; Moura MS; Dias MA; Lins BD; Paula EV; Vassallo J; Annichino-Bizzachi J Platelets; 2015; 26(3):263-6. PubMed ID: 24853254 [TBL] [Abstract][Full Text] [Related]
34. [Idiopathic thrombotic thrombocytopenic purpura or Moschowitz syndrome: current physiopathologic and therapeutic perspectives]. Retornaz F; Durand JM; Poullin P; Lefèvre P; Soubeyrand J Rev Med Interne; 2000 Sep; 21(9):777-84. PubMed ID: 11039173 [TBL] [Abstract][Full Text] [Related]
35. ADAMTS13 Testing Methodologies and Thrombotic Thrombocytopenic Purpura (TTP): Conflicting Results Can Pose a Clinical Dilemma. Pandey S; Cottler-Fox M Ann Clin Lab Sci; 2018 May; 48(3):373-376. PubMed ID: 29970443 [TBL] [Abstract][Full Text] [Related]
36. The association of pregnancy with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. George JN Curr Opin Hematol; 2003 Sep; 10(5):339-44. PubMed ID: 12913787 [TBL] [Abstract][Full Text] [Related]
37. Successful use of rituximab in a patient with refractory thrombotic thrombocytopaenic purpura complicated by polymyositis. Takada H; Hosoya T; Kimura N; Kawahata K; Kohsaka H Scand J Rheumatol; 2017 Mar; 46(2):163-165. PubMed ID: 27309121 [No Abstract] [Full Text] [Related]
38. Inherited thrombotic thrombocytopenic purpura mimicking immune thrombocytopenic purpura during pregnancy: a case report. Romão de Souza V; Beatriz Cavalcante de Oliveira A; Maria Vanderlei A; Queiroz da Mota Silveira Aroucha A; Pontes Duarte B; Nunes Machado A; Netto Chaer L; Wanderley de Barros Correia C; da Conceição de Barros Correia M; Freire Hazin Costa M J Med Case Rep; 2018 Jan; 12(1):15. PubMed ID: 29357939 [TBL] [Abstract][Full Text] [Related]
39. Peak ADAMTS13 activity to assess ADAMTS13 conformation and risk of relapse in immune-mediated thrombotic thrombocytopenic purpura. Prasannan N; Dragunaite B; Subhan M; Thomas M; de Groot R; Singh D; Vanhoorelbeke K; Scully M Blood; 2024 Jun; 143(25):2644-2653. PubMed ID: 38502824 [TBL] [Abstract][Full Text] [Related]
40. Measurement of ADAMTS13 activity and inhibitors. Miyata T; Kokame K; Banno F Curr Opin Hematol; 2005 Sep; 12(5):384-9. PubMed ID: 16093784 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]